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Background: Despite increasing prevalence and burden of disease in the elderly, little is known about the management and outcomes of ACS 
in this group. Furthermore, unique features of nonagenarian AMI patients have not been well known, because of the paucity of the nonagenarian 
population. 
Methods: We compared clinical characteristics, management, in-hospital and 1-year clinical outcomes of nonagenarian AMI patients (n=270, 
92.3±2.3 years old) with octogenarian AMI patients (n=2,145, 83.5±2.7 years old) enrolled in Korean AMI Registry (KAMIR). In-hospital outcome was 
defined as in-hospital mortality and complications. One-year clinical outcome was defined as the composite of 1-year major adverse cardiac events 
(MACE).
Results: Nonagenarians were less likely to have hypertension (46.7% vs. 57.5%, p=0.001), diabetes (15.6% vs. 27.9%, p<0.001) compared with 
octogenarians. PCI (57.2% vs. 71.6%, p<0.001) was preferred and glycoprotein IIb/IIIa inhibitors (5.2% vs. 10.9%, p=0.004) were more likely to be 
used in octogenarians than nonagenarians. However, the success rate of PCI between the two groups was comparable (96.8% vs. 96.7%, p=0.984). 
Also, angiographic findings were comparable between the two groups. Beta-blocker (60.0% vs. 69.3%, p=0.002) and statin (65.6% vs. 71.7%, 
p=0.036) were less prescribed in nonagenarians compared with octogenarians. In-hospital mortality was higher in nonagenarians compared with 
octogenarians (15.7% vs. 11.4%, p=0.040). However, in-hospital complications were comparable between the two groups including acute renal 
failure, multi-organ failure, fatal arrhythmia, new onset heart failure, cardiogenic shock, and major bleeding. One-year MACE rate in patients who 
survived at hospital discharge were comparable between the two groups (25.4% vs. 22.7%, p=0.501), although cardiac death was more commonly 
occurred in nonagenarians than octogenarians (13.6% vs. 8.1%, p=0.044).
Conclusions: Although PCI was less preferred in nonagenarian AMI patients, it might be performed as safe as octogenarian AMI patients without 
increment of re-PCI rate. Also, attention to secondary prevention in nonagenarian AMI patients should be uplifted cautiously.
